Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa Driven Platelet Activation Via Protease Activated Receptor-1.
2019
Rationale: A reduced rate of myocardial infarction has been reported in patients with atrial fibrillation (AF) treated with factor Xa (FXa) inhibitors including rivaroxaban (RIVA) compared to vitam...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
63
References
39
Citations
NaN
KQI